AU6043296A - Chemically modified oligonucleotide for site-directed mutage nesis - Google Patents

Chemically modified oligonucleotide for site-directed mutage nesis

Info

Publication number
AU6043296A
AU6043296A AU60432/96A AU6043296A AU6043296A AU 6043296 A AU6043296 A AU 6043296A AU 60432/96 A AU60432/96 A AU 60432/96A AU 6043296 A AU6043296 A AU 6043296A AU 6043296 A AU6043296 A AU 6043296A
Authority
AU
Australia
Prior art keywords
site
chemically modified
modified oligonucleotide
nesis
directed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60432/96A
Inventor
Peter M Glazer
Pamela A Havre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Publication of AU6043296A publication Critical patent/AU6043296A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3511—Conjugate intercalating or cleaving agent
AU60432/96A 1995-06-06 1996-06-04 Chemically modified oligonucleotide for site-directed mutage nesis Abandoned AU6043296A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46351995A 1995-06-06 1995-06-06
US463519 1995-06-06
PCT/US1996/008883 WO1996039195A2 (en) 1995-06-06 1996-06-04 Chemically modified oligonucleotide for site-directed mutagenesis

Publications (1)

Publication Number Publication Date
AU6043296A true AU6043296A (en) 1996-12-24

Family

ID=23840376

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60432/96A Abandoned AU6043296A (en) 1995-06-06 1996-06-04 Chemically modified oligonucleotide for site-directed mutage nesis

Country Status (2)

Country Link
AU (1) AU6043296A (en)
WO (1) WO1996039195A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136601A (en) * 1991-08-21 2000-10-24 Epoch Pharmaceuticals, Inc. Targeted mutagenesis in living cells using modified oligonucleotides
US11918695B2 (en) 2014-05-09 2024-03-05 Yale University Topical formulation of hyperbranched polymer-coated particles
PL3140269T3 (en) 2014-05-09 2024-03-11 Yale University Hyperbranched polyglycerol-coated particles and methods of making and using thereof
EP3416976A2 (en) 2016-02-16 2018-12-26 Yale University Compositions for enhancing targeted gene editing and methods of use thereof
US20200308590A1 (en) 2016-02-16 2020-10-01 Yale University Compositions and methods for treatment of cystic fibrosis
WO2018187493A1 (en) 2017-04-04 2018-10-11 Yale University Compositions and methods for in utero delivery
US20210189431A1 (en) 2018-08-10 2021-06-24 Yale University Compositions and methods for embryonic gene editing in vitro
SG11202101984PA (en) 2018-08-31 2021-03-30 Univ Yale Compositions and methods for enhancing triplex and nuclease-based gene editing
WO2020112195A1 (en) 2018-11-30 2020-06-04 Yale University Compositions, technologies and methods of using plerixafor to enhance gene editing
US20220243211A1 (en) 2019-06-21 2022-08-04 Yale University Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
WO2020257779A1 (en) 2019-06-21 2020-12-24 Yale University Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
US20220339294A1 (en) 2019-09-09 2022-10-27 Yale University Nanoparticles for selective tissue or cellular uptake

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0253193B1 (en) * 1986-07-08 1992-10-28 Abbott Laboratories Method for mutagenesis by oligonucleotide-directed repair of a strand break
JP3398957B2 (en) * 1991-12-24 2003-04-21 ザ・プレジデント・アンド・フエローズ・オブ・ハーバード・カレツジ Mutagenesis of specific sites in DNA
DE69407590T2 (en) * 1993-06-25 1998-07-23 Univ Yale New Haven CHEMICAL-MODIFIED OLIGONUCLEOTIDES FOR SITE-SPECIFIC MUTAGENESIS

Also Published As

Publication number Publication date
WO1996039195A3 (en) 1997-01-30
WO1996039195A2 (en) 1996-12-12

Similar Documents

Publication Publication Date Title
AU5050096A (en) Catalysts
AU5235796A (en) o-hydroxyphenyl-s-triazines
AU4780896A (en) Core-board
AU5896396A (en) Pyridine-microbicides
AU5346096A (en) Bed
AU1030997A (en) Taphane
AU3855495A (en) Cat litter-tray
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AU5147496A (en) Fucopeptides
AU6043296A (en) Chemically modified oligonucleotide for site-directed mutage nesis
AU7604096A (en) Gameboard
AU5593896A (en) Benzisothiazolyl-substituted aminomethylchromans
AU4382896A (en) Acetylimidazobenzodiazepines
AU5500196A (en) Anti-transpirants
AU4736496A (en) Muffler
AU5108596A (en) Morphine-3-esters
AU5770896A (en) Catalytic nitration
AU7287596A (en) Strengthening agent
AU5917896A (en) Poly-beta-1-4-N-acetylglucosamine
AU6821096A (en) Catalyst use
AU5013796A (en) Wireclamp
AU5107096A (en) Haemodialyser
AU1093697A (en) Active bio-compounds
AU4569496A (en) Tetralinyl- and indanyl-ethylamides
AU6369996A (en) Anti-piroplasmotic agent